Concepedia

Author

James P. Allison

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

Allison, James, Allison, James P., J ALLISON, J Allison, J P Allison, J. Allison, J. P. ALLISON, J. P. Allison, J.P Allison, J.P. ALLISON

1.2K

Publications

118.6K

Citations

157

H-Index

248

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterMemorial Sloan Kettering Cancer CenterUniversity of California, BerkeleyHoward Hughes Medical InstituteUniversity of California, San Francisco
JP

About

James P. Allison is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

13

16

1.3K

2

Engineering

4

4

172

3

Business

2

2

33

4

Education

1

1

24

5

Management

1

1

17

James P. Allison

×

362

Publications

92.8K

Citations

136

H-Index

YearCitations

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi,

Science

2017

4.4K

Restoring function in exhausted CD8 T cells during chronic viral infection

Daniel L. Barber, E. John Wherry, David Masopust,

Nature

2005

3.9K

Enhancement of Antitumor Immunity by CTLA-4 Blockade

Dana R. Leach, Matthew F. Krummel, James P. Allison

Science

1996

3.9K

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Berna C. Özdemir, Tsvetelina Pentcheva‐Hoang, Julienne L. Carstens,

Cancer Cell

2014

2.5K

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Matthew F. Krummel, James P. Allison

The Journal of Experimental Medicine

1995

2.2K

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow, Margaret K. Callahan, Christopher A. Barker,

New England Journal of Medicine

2012

2K

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster,

Nature

2014

2K

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Michael A. Curran, Welby Montalvo, Hideo Yagita∥,

Proceedings of the National Academy of Sciences

2010

1.8K

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry,

Proceedings of the National Academy of Sciences

2003

1.6K

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

Fiona Harding, James G. McArthur, Jane A. Gross,

Nature

1992

1.5K

Page 1